MedTrace Logo

Clinical Effect of Chlorhexidine Mouthwash After Periodontal Surgery

NCT04223076 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 31

Last updated 2020-01-13

No results posted yet for this study

Summary

Chlorhexidine is the gold standard of dental plaque prevention. Recent research have demonstrated that 0.2% Chlorhexidine solutions are more effective than 0.12% and 0.06% Chlorhexidine solutions. Several 0.2% solutions are available on the market. This study aimed to compare effectiveness of two commercially available 0.2% chlorhexidine mouthwashes. Patients, that after initial periodontal therapy, had a need for two periodontal surgeries, will be invited to join. After one surgical session, the patient will receive one 0.2% chlorhexidine solution, and after the next surgical session the patient will receive the other 0.2% chlorhexidine solution. Plaque and gingivitis will be recorded, as well as side effects.

Conditions

  • Periodontal Diseases
  • Periodontitis
  • Dental Plaque

Interventions

DRUG

Chlorhexidine 0.2%, Corsodyl

Comparison of Corsodyl and Curasept

DRUG

Chlorhexidine 0.2%, Curasept

Chlorhexidine 0.2% mouthwash with an Anti Discoloring System (ADS)

Sponsors & Collaborators

  • University of Oslo

    lead OTHER

Principal Investigators

  • Anne Merete Aass, Professor · University of Oslo

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-20
Primary Completion
2019-12-20
Completion
2020-12-30

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04223076 on ClinicalTrials.gov